Skip to main content
. 2016 Apr 27;7(22):32846–32853. doi: 10.18632/oncotarget.9055

Table 1. Clinical characteristics of analyzed CLL patients.

Characteristics Median (range) Number of patients/percentage
Sex
Female 30
Male 36
Age 63 (38–85)
Rai stadium
0 31%
I 17%
II 30%
III 8%
IV 14%
CD38 expression
Negative 56%
Positive 44%
ZAP-70 expression
Negative 68%
Positive 32%
Cytogenetics
Low-risk 60%
High-risk 40%
First-line therapy
Fludarabine-based regimens 30
Chlorambucil+/−Prednisone 7
Bendamustine 1